Nasic Pur (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride, the active ingredient in Nasic Pur, is a nasal decongestant (imidazoline derivative) presented as a nasal spray formulation for nasal use. It reduces nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasic Pur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other global markets. The product conforms to EU quality standards and is manufactured under GMP conditions.

Nasic Pur, containing xylometazoline, acts on the nasal mucosa to relieve congestion in several common upper‑respiratory conditions.

- Common cold: alleviates nasal blockage and improves breathing. - Sinusitis: reduces mucosal swelling to facilitate sinus drainage. - Allergic rhinitis: diminishes nasal congestion caused by allergen exposure.

Nasic Pur may cause local and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Nasal burning or stinging sensation. - Mild nasal dryness or irritation. - Sneezing shortly after application. - Transient headache. - Unpleasant taste. - Epistaxis (minor nosebleed).

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use. - Elevated blood pressure or tachycardia. - Severe allergic reaction (anaphylaxis, angioedema). - Nasal ulceration or perforation. - Persistent nasal irritation requiring medical attention.

Before using Nasic Pur, consider the following precautions to ensure safe and effective treatment.

- Duration of use: limit to no more than 3‑5 consecutive days to avoid rebound congestion. - Age restriction: avoid in children under 6 years unless advised by a physician. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Concomitant decongestants: do not combine with other nasal or oral decongestants without medical guidance. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Systemic antihypertensive agents: additive blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Other topical nasal decongestants: increased risk of rebound congestion. - Oral sympathomimetic decongestants (e.g., pseudoephedrine): potential for excessive vasoconstriction. - Certain ophthalmic decongestant drops: may enhance systemic adrenergic effects.